Bliss Group names Cortney Stapleton CEO

Published on 1st March 2023

Our partner, The Bliss Group based in New York, U.S.  has promoted Cortney Stapleton to CEO. She will prepare the firm for a sustainable growth path led by new practice development and the integration of data science and analytics throughout its entire offering. The agency also launched Bliss Bio, a healthcare initiative, last year, with plans to continue a focus on professional services, financial services, healthcare and tech in partnerships with clients this year.

Read more on: Bliss Group names Cortney Stapleton CEO

Related Insights

08 Jul 2026

The Invisible Race: How Pharmaceutical Brands Win or Lose in the Age of AI Search

For decades, pharmaceutical companies have competed on search engine results pages. They…

Read more

08 Jul 2026

Built to Trust or Built to Fail? The Real State of Pharma Corporate Websites

A pharmaceutical company’s corporate website is more than a digital presence. It…

Read more

08 Jul 2026

One Message, Many Doors: Why Pharma's Localization Gap Is Costing It Credibility

There is a paradox at the heart of pharmaceutical communications. The sector…

Read more